SCHEMBL8307186

SCHEMBL8307186

C/C(=N/OCCO)c1ccc2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
HPGD P15428 3/20 0.48
MET P08581 7/20 0.43
CNR2 P34972 1/20 0.43
MGAM O43451 1/20 0.42
MAPT P10636 5/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.42
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
ATM Q13315 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307187 1.00 ALDH1A1 (0.48) ALDH1A1HPGDMETCNR2MGAM
SCHEMBL10273815 0.78 ALDH1A1 (0.39) ALDH1A1HPGDCNR2MGAMMAPT
SCHEMBL8686194 0.75 KMT2A (0.44) ALDH1A1HPGDCNR2MGAMMAPT
SCHEMBL8308456 0.74 KDM4C (0.44) ALDH1A1HPGDMAPTLMNAGAA
SCHEMBL8307051 0.74 MGAM (0.53) ALDH1A1HPGDCNR2MGAMMAPT
SCHEMBL14190711 0.73 ALDH1A1 (0.45) ALDH1A1HPGDCNR2MGAMMAPT
SCHEMBL8304591 0.73 PPARG (0.58) ALDH1A1HPGDMAPTLMNARAB9A
SCHEMBL8304592 0.73 PPARG (0.58) ALDH1A1HPGDMAPTLMNARAB9A
SCHEMBL8306601 0.71 HIF1A (0.42) ALDH1A1METLMNARAB9ASMN1; SMN2
SCHEMBL8306603 0.71 HIF1A (0.42) ALDH1A1METLMNARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed